Skip to main content

MARSHALL WACE, LLP

Position in AMPH — Amphastar Pharmaceuticals, Inc.

CIK 1318757 LONDON, X0

Position in AMPH

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$20,092,287
-$13,042,177 QoQ
Shares Held
1,025,640
-17.1% QoQ
Ownership
2.33%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in AMPH Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $558,161,566 across 33 Drug Manufacturers - Specialty & Generic names. AMPH ranks #10 (3.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AMPH

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $20,092,287 1,025,640
2025-12-31 $33,134,464 1,237,284
2025-09-30 $23,293,912 874,068
2025-06-30 $19,485,806 848,685
2025-03-31 $29,909,619 1,031,722
2024-12-31 $22,601,253 608,706
2024-09-30 $27,589,013 568,494
2024-06-30 $9,085,080 227,127
2023-03-31 $2,407,837 64,209
2022-09-30 $889,027 31,638
2022-06-30 $989,462 28,441
2022-03-31 $625,270 17,417
2020-06-30 $2,969,840 132,228
2020-03-31 $4,480,344 301,910